2.31
-0.07 (-2.94%)
| Penutupan Terdahulu | 2.38 |
| Buka | 2.36 |
| Jumlah Dagangan | 77,206 |
| Purata Dagangan (3B) | 96,907 |
| Modal Pasaran | 94,176,384 |
| Harga / Pendapatan (P/E TTM) | 4.53 |
| Harga / Jualan (P/S) | 152.49 |
| Harga / Buku (P/B) | 0.620 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 7 Nov 2024 |
| EPS Cair (TTM) | 0.110 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.28% |
| Nisbah Semasa (MRQ) | 27.08 |
| Aliran Tunai Operasi (OCF TTM) | -7.92 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -2.41 M |
| Pulangan Atas Aset (ROA TTM) | -4.12% |
| Pulangan Atas Ekuiti (ROE TTM) | 2.89% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Oramed Pharmaceuticals Inc. | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 3.5 |
| Purata | 0.50 |
|
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 10.62% |
| % Dimiliki oleh Institusi | 17.52% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 07 Oct 2024 | Pengumuman | Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |